tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB
Holding MTNB?
Track your performance easily

Matinas BioPharma (MTNB) Technical Analysis

1,518 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Matinas BioPharma’s (MTNB) Moving Averages Convergence Divergence (MACD) indicator is -0.65, suggesting Matinas BioPharma is a Sell.
Matinas BioPharma’s (MTNB) 20-Day exponential moving average is 1.16, while Matinas BioPharma’s (MTNB) share price is $0.616, making it a Sell.
Matinas BioPharma’s (MTNB) 50-Day exponential moving average is 2.45, while Matinas BioPharma’s (MTNB) share price is $0.616, making it a Sell.

Matinas BioPharma (MTNB) Pivot Points

Nov 22, 2024, 11:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.49
0.51
0.53
0.55
0.57
0.59
0.60
Fibonacci
0.51
0.53
0.54
0.55
0.57
0.58
0.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Matinas BioPharma (MTNB) Moving Averages

Nov 22, 2024, 11:59 PM
Period
Simple
Exponential
MA5
0.58Sell
0.59Sell
MA10
0.66Sell
0.71Sell
MA20
1.06Sell
1.16Sell
MA50
2.52Sell
2.45Sell
MA100
4.69Sell
4.14Sell
MA200
7.52Sell
6.75Sell
Matinas BioPharma’s (MTNB) 10-Day exponential moving average is 0.71, while Matinas BioPharma’s (MTNB) share price is $0.616, making it a Sell.
Matinas BioPharma’s (MTNB) 100-Day exponential moving average is 4.14, while Matinas BioPharma’s (MTNB) share price is $0.616, making it a Sell.
Matinas BioPharma’s (MTNB) stock price is $0.616 and Matinas BioPharma’s (MTNB) 50-day simple moving average is 2.52, creating a Sell signal.
Matinas BioPharma’s (MTNB) stock price is $0.616 and Matinas BioPharma’s (MTNB) 100-day simple moving average is 4.69, creating a Sell signal.
Matinas BioPharma’s (MTNB) stock price is $0.616 and Matinas BioPharma’s (MTNB) 200-day simple moving average is 7.52, creating a Sell signal.

Matinas BioPharma (MTNB) Technical Indicators

Nov 22, 2024, 11:59 PM
Name
Value
Implied Action
RSI (14)
23.95
Buy
STOCH (9,6)
10.34
Buy
STOCHRSI (14)
10.34
Buy
MACD (12,26)
-0.65
Sell
ADX (14)
40.41
Neutral
Williams %R
-86.21
Buy
CCI (14)
-47.93
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
48.89
Neutral
ROC
0.00
-
Matinas BioPharma’s (MTNB) Relative Strength Index (RSI) is 23.95, creating a Buy signal.
Matinas BioPharma’s (MTNB) Trend Strength Indicator (ADX) is 40.41, creating a Neutral signal.
Matinas BioPharma’s (MTNB) Commodity Channel Index (CCI) is -47.93, creating a Neutral signal.

FAQ

Is MTNB a Buy, Hold, or Sell?
Based on MTNB’s technical indicators, MTNB is a Sell.
    What is MTNB’s RSI (14)?
    MTNB’s RSI (14) is 23.95, which suggests MTNB is a Buy.
      What is MTNB’s MACD?
      MTNB’s MACD is -0.65, which suggests MTNB is a Sell.
        What is MTNB’s 5-day moving average?
        MTNB’s 5-day moving average is 0.58, which suggests MTNB is a Sell.
          What is MTNB’s 20-day moving average?
          MTNB 20-day moving average is 1.06, which suggests MTNB is a Sell.
            What is MTNB’s 50-day moving average?
            MTNB’s 50-day moving average is 2.52, which suggests MTNB is a Sell.
              What is MTNB’s 200-day moving average?
              MTNB’s 200-day moving average is 7.52, which suggests MTNB is a Sell.
                What is MTNB’s Williams % R (14)?
                MTNB’s Williams % R (14) is -86.21, which suggests MTNB is a Buy.
                  What is MTNB’s CCI (14)?
                  MTNB’s CCI (14) is -47.93, which suggests MTNB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis